Overview of the Surviving Sepsis Campaign Current Philosophy for the Management and Treatment of Sepsis and Severe Sepsis SCCM5270
(Michael H. Ackerman, DNS, RN, CS, FCCM)
|
CD $15.00
|
|
Early Goal-directed Therapy in the Treatment of Severe Sepsis and Septic Shock SCCM5271
(Nathan Lidsky, MD)
|
CD $15.00
|
|
Improving Mortality in Sepsis: Updates in the Science SCCM5272
(Nathan Lidsky, MD)
|
CD $15.00
|
|
How to Achieve the Goals of the Surviving Sepsis Campaign at Your Institution SCCM5273
(Thomas S. Ahrens, DNS, RN, CCRN, CS)
|
CD $15.00
|
|
Panel Discussion: Controversies in the Treatment of Sepsis and Issues with Implementation of Identified Treatments SCCM5274
(Michael H. Ackerman, DNS, RN, CS, FCCM, Thomas S. Ahrens, DNS, RN, CCRN, CS, Nathan Lidsky, MD)
|
CD $15.00
|
|
Clinical and Economic Benefits of Tight Glycemic Control in Critically Ill Patients SCCM5276
(James S. Krinsley, MD)
|
CD $15.00
|
|
Perils of Dosing, Monitoring, Adjusting, and Reversing Anticoagulants in the ICU SCCM5277
(William E. Dager, PharmD)
|
CD $15.00
|
|
Sedation Titration - Are Sedation Scores Enough or Should Bispectral Index Monitoring Be Used? SCCM5278
(John W. Devlin, PharmD, BCPS, FCCM)
|
CD $15.00
|
|
Stress Ulcer Prophylaxis and Pharmacotherapy for Acute GI Bleed SCCM5279
(Lynda S. Welage, PharmD)
|
CD $15.00
|
|
Considerations for Adjusting Selected Medications During Continuous or Extended Renal Replacement Therapy in the ICU SCCM5280
(William E. Dager, PharmD)
|
CD $15.00
|
|
Toxic Syndromes of Commonly Used Drugs SCCM5281
(Sergio L. Zanotti, MD)
|
CD $15.00
|
|
Antidotes and Therapeutic Agents for Treatment of Poisoning and Overdoses SCCM5282
(Janice L. Zimmerman, MD, FCCM)
|
CD $15.00
|
|
The Role of Critical Care and the Hospital in Disaster Medical Response SCCM5283
(J. Christopher Farmer, MD, FCCM)
|
CD $15.00
|
|
All 13 sessions in MP3 audio format, $99.00. SCCM5270mp3
|
MP3 Disk $99.00
|
|
Audio Visual Education Network
View Cart
